US regenerative medicine firm Forever Labs has formally spun out SuperShot as a standalone business, a move the company says ...

The European Commission (EC) has approved a Marketing Authorization (MA) for Tremfya (guselkumab) to treat adults with ...

The American medicines regulator will convene its vaccine advisory committee on May 22 to weigh in on which strains should be ...

Sino-American biotech BeiGene (Nasdaq: ONC; HKEX 06160) today announced that the European Commission has approved Tevimbra ...

Massachusetts-based PAQ Therapeutics, a biotech developing KRAS degraders for cancers lacking effective treatment options, ...

Japanese drugmaker Shionogi (TYO: 4507) is to scale up its pipeline and global ambitions with a deal worth more than $1 ...

Privately-held Italian firm Sibylla Biotech today announced the appointment of Dieter Weinand as chairman of its board of ...

Japanese drugmaker Takeda (TSE: 4502) posted revenue of 4.58 trillion yen ($31.7 billion) for the fiscal year ended March 31, ...

As the US government, under President Donald Trump, is on the verge of announcing significant new tariffs on pharmaceutical ...

UK-based specialty pharma business Kelso Pharma has appointed Bee Koen Low as its first chief operating officer (COO).

Pharmaceutical and Research Manufacturers of America (PhRMA) yesterday submitted comments to the US Department of Commerce on ...

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) yesterday approved Tepezza (teprotumumab (Tepezza). This ...